Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Drug Classes and Categories01:25

Drug Classes and Categories

1.8K
Drugs can be classified according to their chemical composition or their intended therapeutic application. For instance, anti-infective agents that possess the ability to eliminate pathogens or suppress their growth and reproduction can be grouped based on the organisms they target or their chemical structure. Furthermore, drugs can be divided into prescription, nonprescription, or controlled substances. Prescription medications, such as antibiotics, require oversight from a licensed healthcare...
1.8K
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids01:25

Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids

131
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
131
Local Anesthetics: Common Agents and Their Applications01:23

Local Anesthetics: Common Agents and Their Applications

364
Local anesthetics (LAs) are commonly used for various applications in medical and dental procedures. Some of the common agents used are cocaine, lidocaine, and bupivacaine.
Cocaine is an ester of benzoic acid and methylecgogine. It is used to anesthetize and vasoconstrict locally. Currently, it is used primarily for topical applications. It is beneficial for surgeries on the upper respiratory tract, providing anesthesia and shrinking the mucosa. Cocaine in the form of cocaine hydrochloride is...
364
Drug Nomenclature01:17

Drug Nomenclature

1.5K
During the development of a new pharmaceutical, the manufacturer initially assigns a code name to the drug. Once approved, the drug receives a United States Adopted Name (USAN)—a generic, nonproprietary designation. Upon being listed in the United States Pharmacopeia, this nonproprietary name becomes the drug's official name. Additionally, the manufacturer assigns a proprietary name or trademark, which serves as the brand name under which the drug is marketed. It is worth noting that...
1.5K
Cardiovascular Drugs: Classification based on Therapeutic Indications01:18

Cardiovascular Drugs: Classification based on Therapeutic Indications

1.8K
Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
1.8K
Dose-Response Relationship: Potency and Efficacy01:22

Dose-Response Relationship: Potency and Efficacy

4.0K
The potency of a drug is the measure of its ability to produce a biological response and can be compared by looking at the half-maximum effective concentration or EC50 values of different drugs. A lower EC50 value indicates higher potency of the drug. In the dose–response curve of two antihypertensive drugs, candesartan and irbesartan, a significant difference is observed in their EC50 values. A lower EC50 value for candesartan indicates that it is more potent than irbesartan, as it...
4.0K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Skin Cancer in the Rural South: Strengthening Dermatologic Training for Frontline Primary Care.

Cureus·2026
Same author

Longer Pembrolizumab Therapy Reduces Mortality in Stage III and IV Melanoma: A TriNetX Study.

Journal of drugs in dermatology : JDD·2026
Same author

Excited Skin Syndrome (Angry Back), What Do We Know About It? A Review of the Literature.

Journal of cosmetic dermatology·2026
Same author

The Effect of Sequential Topical Application of Dermatologic Medications on Absorption: Clinical Considerations.

Skin pharmacology and physiology·2026
Same author

Eyelid dermatitis: Work-up and future diagnostic innovative solutions.

Progress in retinal and eye research·2025
Same author

Neurocosmetics are cosmetics, which mean that they could have effects only on skin.

Clinics in dermatology·2025

相关实验视频

Updated: May 9, 2025

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis
11:39

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis

Published on: July 11, 2013

38.7K

局部皮质类固醇强度:重新想象一个新的通用分类系统

Taylor C Skinner, Rebecca M Law, Howard I Maibach

    Journal of drugs in dermatology : JDD
    |May 6, 2025
    PubMed
    概括

    局部皮质类固醇 (TCS) 广泛用于皮肤疾病,但缺乏普遍的强度分类. 本综述提出了一个统一的系统,以减少这些强效药物的处方混乱.

    科学领域:

    • 皮肤病学 皮肤病学
    • 药理学 药理学是指药理学的学科.

    背景情况:

    • 局部皮质类固醇 (TCS) 是许多皮肤病的基石治疗.
    • 它们的有效性和耐受性已经得到了很好的证明,但缺乏标准化的强度分类阻碍了它们的最佳使用.

    研究的目的:

    • 审查和综合有关局部皮质类固醇功效和分类系统的现有文献.
    • 提出一个新的,通用的TCS分类系统,以提高清晰度和一致性.

    主要方法:

    • 综合的文献搜索和对现有的TCS功效数据的分析.
    • 对当前局部皮质类固醇国际分类框架的评估.

    主要成果:

    • 目前的TCS分类系统是分散的,缺乏普遍接受.
    • 在不同地区的TCS强度分类方式中存在显著的变化.

    结论:

    • 需要一个统一的,普遍接受的局部皮质类固醇的分类系统.
    • 拟议的系统旨在通过减少TCS选择中的混乱来简化临床决策和改善患者的结果.

    更多相关视频

    Author Spotlight: Self-Assessment Protocol for Predicting Psoriatic Arthritis in Psoriasis Patients
    02:28

    Author Spotlight: Self-Assessment Protocol for Predicting Psoriatic Arthritis in Psoriasis Patients

    Published on: March 1, 2024

    309
    Minimal Erythema Dose MED Testing
    06:24

    Minimal Erythema Dose MED Testing

    Published on: May 28, 2013

    41.3K

    相关实验视频

    Last Updated: May 9, 2025

    The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis
    11:39

    The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis

    Published on: July 11, 2013

    38.7K
    Author Spotlight: Self-Assessment Protocol for Predicting Psoriatic Arthritis in Psoriasis Patients
    02:28

    Author Spotlight: Self-Assessment Protocol for Predicting Psoriatic Arthritis in Psoriasis Patients

    Published on: March 1, 2024

    309
    Minimal Erythema Dose MED Testing
    06:24

    Minimal Erythema Dose MED Testing

    Published on: May 28, 2013

    41.3K